Lifebank Cryogenics Corp.

Lifebank Cryogenics Corp.

July 11, 2005 20:34 ET

Lifebank Grants Stock Options

BURNABY, BRITISH COLUMBIA--(CCNMatthews - July 11, 2005) - Lifebank Cryogenics Corp. (the "Company")(TSX VENTURE:LBK) announces that, under it's stock option plan, it has granted incentive stock options to directors, officers and employees of the Company to purchase up to a total aggregate of 387,500 Common shares in the capital stock of the Company at a price of $0.12 per share. The options are exercisable for a period of five years ending on July 8, 2010.

Lifebank is a biomedical service company that provides processing and cryogenic (ultra low temperature) storage of umbilical cord blood stem cells. It is the first AABB accredited umbilical cord blood stem cell bank in Canada. Lifebank has successfully stored stem cell samples for clients in Canada and the rest of the world. Lifebank is dedicated to providing its clients with the finest cord blood stem cell processing, analysis and cryogenic storage services available in the world. Lifebank strives to work closely with physicians and public institutions in order to provide life saving cord blood services to any and all persons in need.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information